Discrimination between RRR- and all-racemic-alpha-tocopherols labeled with deuterium by patients with abetalipoproteinemia.

@article{Traber1994DiscriminationBR,
  title={Discrimination between RRR- and all-racemic-alpha-tocopherols labeled with deuterium by patients with abetalipoproteinemia.},
  author={Maret G Traber and Daniel R Rader and Robert V Acuff and Hollis B Brewer and Herbert J. Kayden},
  journal={Atherosclerosis},
  year={1994},
  volume={108 1},
  pages={27-37}
}
The ability to discriminate between stereoisomers of alpha-tocopherol was studied in five patients with abetalipoproteinemia (ABL) because an impairment in secretion of apolipoprotein B-containing lipoproteins might impede the normally enhanced plasma transport of RRR-alpha-tocopherol. An oral dose containing 3.7 g of each 2R, 4'R,8'R-alpha-[5-C2H3… CONTINUE READING